Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. Wang-Gohrke S, et al. Among authors: runnebaum ib. Anticancer Res. 1998 May-Jun;18(3B):2095-9. Anticancer Res. 1998. PMID: 9677474
Mutations in p53 as potential molecular markers for human breast cancer.
Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S. Runnebaum IB, et al. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10657-61. doi: 10.1073/pnas.88.23.10657. Proc Natl Acad Sci U S A. 1991. PMID: 1961733 Free PMC article.
p53 gain-of-function mutation in codon 175 is a rare event in human breast cancer.
Runnebaum IB, Kieback DG, Tong XW, Kreienberg R. Runnebaum IB, et al. Hum Mol Genet. 1993 Sep;2(9):1501-2. doi: 10.1093/hmg/2.9.1501. Hum Mol Genet. 1993. PMID: 7902164 No abstract available.
p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6.
Runnebaum IB, Tong XW, Möbus VJ, Kieback DG, Rosenthal HE, Kreienberg R. Runnebaum IB, et al. FEBS Lett. 1994 Oct 10;353(1):29-32. doi: 10.1016/0014-5793(94)00953-8. FEBS Lett. 1994. PMID: 7926016
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.
Runnebaum IB, Tong XW, Moebus V, Heilmann V, Kieback DG, Kreienberg R. Runnebaum IB, et al. Hum Genet. 1994 Jun;93(6):620-4. doi: 10.1007/BF00201559. Hum Genet. 1994. PMID: 8005584
Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
Runnebaum IB, Yee JK, Kieback DG, Sukumar S, Friedmann T. Runnebaum IB, et al. Anticancer Res. 1994 May-Jun;14(3A):1137-44. Anticancer Res. 1994. PMID: 8074464
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL).
Kieback DG, Press MF, Atkinson EN, Edwards GL, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA. Kieback DG, et al. Among authors: runnebaum ib. Anticancer Res. 1993 Nov-Dec;13(6B):2489-96. Anticancer Res. 1993. PMID: 8135488
Subcellular localization of accumulated p53 in ovarian cancer cells.
Runnebaum IB, Kieback DG, Mobus VJ, Tong XW, Kreienberg R. Runnebaum IB, et al. Gynecol Oncol. 1996 May;61(2):266-71. doi: 10.1006/gyno.1996.0137. Gynecol Oncol. 1996. PMID: 8626145
Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53.
Runnebaum IB, Wang S, Kreienberg R. Runnebaum IB, et al. J Cell Biochem. 1995 Dec;59(4):537-44. doi: 10.1002/jcb.240590413. J Cell Biochem. 1995. PMID: 8749722
177 results
Jump to page